Published in Z Rheumatol on May 01, 2005
[Rheumatoid arthritis and cardiovascular complications]. Z Rheumatol (2006) 0.88
Atherosclerosis--an inflammatory disease. N Engl J Med (1999) 59.28
The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (1980) 40.02
The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum (1987) 14.21
The mortality of rheumatoid arthritis. Arthritis Rheum (1994) 6.18
High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum (2001) 5.87
Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum (2005) 5.31
Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest (1995) 5.09
Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res (2004) 4.67
Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood (1997) 4.01
Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. Arthritis Rheum (2002) 3.53
Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis Rheum (2003) 3.35
Endothelial function: a barometer for cardiovascular risk? Circulation (2002) 3.31
Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection. Nat Med (2000) 3.10
A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation (2002) 2.76
Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation (2000) 2.56
Interferon-gamma elicits arteriosclerosis in the absence of leukocytes. Nature (2000) 2.55
Blood pressure and inflammation in apparently healthy men. Hypertension (2001) 2.55
Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood (2000) 2.51
Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation (2002) 2.45
Defective vasculogenesis in systemic sclerosis. Lancet (2004) 2.38
Perturbation of the T cell repertoire in rheumatoid arthritis. Proc Natl Acad Sci U S A (1998) 2.33
C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation (2003) 2.16
Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation (1999) 2.14
Expansion of unusual CD4+ T cells in severe rheumatoid arthritis. Arthritis Rheum (1997) 2.11
Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol (2002) 2.01
Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res (1993) 1.98
C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation (2004) 1.94
Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway. J Biol Chem (1999) 1.82
TNF signaling in vascular endothelial cells. Exp Mol Pathol (2001) 1.78
Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis. Circulation (2005) 1.75
Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study. Ann Rheum Dis (2004) 1.75
Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis. Ann Rheum Dis (2004) 1.73
The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles. Proc Natl Acad Sci U S A (2005) 1.71
Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis. J Clin Invest (1995) 1.69
Endothelium-derived microparticles impair endothelial function in vitro. Am J Physiol Heart Circ Physiol (2004) 1.68
Cell-derived microparticles in synovial fluid from inflamed arthritic joints support coagulation exclusively via a factor VII-dependent mechanism. Arthritis Rheum (2002) 1.67
Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms. Thromb Haemost (2001) 1.65
Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte-endothelial interactions. Arterioscler Thromb Vasc Biol (2002) 1.62
Functional subsets of CD4 T cells in rheumatoid synovitis. Arthritis Rheum (1998) 1.56
Tumor necrosis factor-alpha inhibits endothelial nitric-oxide synthase gene promoter activity in bovine aortic endothelial cells. J Biol Chem (2003) 1.41
Immunosenescence, autoimmunity, and rheumatoid arthritis. Exp Gerontol (2003) 1.38
Coronary artery disease and rheumatoid arthritis. Curr Opin Rheumatol (2002) 1.37
CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation (2004) 1.36
HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis. Am J Med (2003) 1.36
Nitric oxide synthase gene therapy rapidly reduces adhesion molecule expression and inflammatory cell infiltration in carotid arteries of cholesterol-fed rabbits. Circulation (1999) 1.35
Rheumatoid factor, chronic arthritis and mortality. Ann Rheum Dis (1995) 1.26
Endothelial and platelet microparticles in vasculitis of the young. Arthritis Rheum (2004) 1.25
C-reactive protein enhances LOX-1 expression in human aortic endothelial cells: relevance of LOX-1 to C-reactive protein-induced endothelial dysfunction. Circ Res (2004) 1.23
Shed membrane particles from T lymphocytes impair endothelial function and regulate endothelial protein expression. Circulation (2004) 1.21
Particular HLA-DRB1 shared epitope genotypes are strongly associated with rheumatoid vasculitis. Arthritis Rheum (2004) 1.20
Activation of NF-kappaB induced by H(2)O(2) and TNF-alpha and its effects on ICAM-1 expression in endothelial cells. Am J Physiol Lung Cell Mol Physiol (2000) 1.19
Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure. Circulation (2001) 1.17
The repertoire of CD4+ CD28- T cells in rheumatoid arthritis. Mol Med (1996) 1.16
Macrophage uptake of low-density lipoprotein bound to aggregated C-reactive protein: possible mechanism of foam-cell formation in atherosclerotic lesions. Biochem J (2002) 1.10
The expansion of CD4+CD28- T cells in patients with rheumatoid arthritis. Arthritis Res Ther (2003) 1.08
C-reactive protein induces apoptosis in human coronary vascular smooth muscle cells. Circulation (2004) 1.05
Human cytokines modulate arterial vascular tone via endothelial receptors. Pflugers Arch (1999) 1.02
Natriuretic factors and nitric oxide suppress plasminogen activator inhibitor-1 expression in vascular smooth muscle cells. Role of cGMP in the regulation of the plasminogen system. Arterioscler Thromb Vasc Biol (1998) 1.00
C-reactive protein activates the nuclear factor-kappaB signal transduction pathway in saphenous vein endothelial cells: implications for atherosclerosis and restenosis. J Thorac Cardiovasc Surg (2003) 0.94
Lipoprotein(a) and lipids in relation to inflammation in rheumatoid arthritis. Clin Rheumatol (2000) 0.93
Inhibition of NO synthesis induces inflammatory changes and monocyte chemoattractant protein-1 expression in rat hearts and vessels. Arterioscler Thromb Vasc Biol (1998) 0.93
T cell-mediated signaling to vascular endothelium: induction of cytokines, chemokines, and tissue factor. J Leukoc Biol (2002) 0.88
Evidence for peripheral impaired glucose handling in patients with connective tissue diseases. Metabolism (1991) 0.87
Glucose intolerance in patients with chronic inflammatory diseases is normalized by glucocorticoids. Acta Med Scand (1983) 0.86
Nitric oxide acts on the mitochondria and protects human endothelial cells from apoptosis. J Lab Clin Med (2004) 0.84
Prospective analysis of the impact of HLA-DR and -DQ on joint destruction in recent-onset rheumatoid arthritis. Rheumatology (Oxford) (2003) 0.83
Therapy with infliximab decreases the CD4+CD28- T cell compartment in peripheral blood in patients with rheumatoid arthritis. Rheumatol Int (2003) 0.81
Effect of C-reactive protein on Fcgamma receptor II in cultured bovine endothelial cells. Clin Sci (Lond) (2005) 0.77
Inducible NO synthesis in the vasculature: molecular context defines physiological response. Arterioscler Thromb Vasc Biol (2001) 0.75
Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol (2000) 7.94
Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage (2005) 6.77
An estrogen-responsive element derived from the 5' flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells. Cell (1986) 5.22
A General Principle Involving Baire Category, with Applications to Function Theory and Other Fields. Proc Natl Acad Sci U S A (1953) 4.89
Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genet (2001) 3.99
Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer. Ann Oncol (2009) 3.63
Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol (1996) 3.59
Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res (2000) 3.27
Spiral and Other Asymptotic Paths, and Paths of Complete Indetermination, of Analytic and Meromorphic Functions. Proc Natl Acad Sci U S A (1953) 3.02
Early sleep triggers memory for early visual discrimination skills. Nat Neurosci (2000) 2.74
The influence of sex on the phenotype of rheumatoid arthritis. Arthritis Rheum (1998) 2.74
Synovial fibroblasts: key players in rheumatoid arthritis. Rheumatology (Oxford) (2006) 2.44
Glutamate receptors regulate actin-based plasticity in dendritic spines. Nat Neurosci (2000) 2.41
2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004). Ann Oncol (2005) 2.33
Collagen: an overview. Methods Enzymol (1982) 2.33
Preparation and use in immunohistology of antibodies specific for type I and type III collagen and procollagen. J Immunol Methods (1976) 2.28
Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade. J Pathol (2001) 2.20
Lyme borreliosis in the severe combined immunodeficiency (scid) mouse manifests predominantly in the joints, heart, and liver. Am J Pathol (1990) 2.15
HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: a potential mechanism for protease inhibitor-induced hyperlipidemia. Nat Med (2001) 2.14
Vitamin A-containing lipocytes and formation of type III collagen in liver injury. Proc Natl Acad Sci U S A (1976) 2.02
Retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue: association with genomic DNA hypomethylation and influence on gene expression. Arthritis Rheum (2000) 2.01
Simultaneous synthesis of types I and III collagen by fibroblasts in culture. Proc Natl Acad Sci U S A (1976) 1.97
Patterns of metastasis in muscle-invasive bladder cancer (pT2-4): An autopsy study on 367 patients. Urol Int (1999) 1.92
Expression of osteoclast differentiation factor in rheumatoid arthritis. Arthritis Rheum (2000) 1.92
Endoscopic ultrasound drainage of pancreatic pseudocyst: a prospective comparison with conventional endoscopic drainage. Endoscopy (2006) 1.90
Antibodies to distinct types of collagens and procollagens and their application in immunohistology. J Immunol Methods (1977) 1.82
High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer. Am J Pathol (2000) 1.82
The collagens: an overview and update. Methods Enzymol (1987) 1.82
Pharyngeal fat in obstructive sleep apnea. Am Rev Respir Dis (1993) 1.80
Collagen content and types in the intestinal strictures of Crohn's disease. Gastroenterology (1988) 1.77
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis (2010) 1.73
Activation of synovial fibroblasts in rheumatoid arthritis: lack of Expression of the tumour suppressor PTEN at sites of invasive growth and destruction. Arthritis Res (2000) 1.73
Angiogenic and angiostatic factors in the molecular control of angiogenesis. Q J Nucl Med (2003) 1.71
High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer. Cancer Res (2001) 1.64
Hepatocyte-specific promoter element HP1 of the Xenopus albumin gene interacts with transcriptional factors of mammalian hepatocytes. J Mol Biol (1988) 1.61
Recongnition by guinea-pig peritoneal exudate cells of conformationally different states of the collagen molecule. Immunology (1976) 1.55
Expression of sentrin, a novel antiapoptotic molecule, at sites of synovial invasion in rheumatoid arthritis. Arthritis Rheum (2000) 1.54
Study of differential collagen synthesis during development of the chick embryo by immunofluroescence. II. Localization of type I and type II collagen during long bone development. Dev Biol (1976) 1.53
Liver cirrhosis: immunofluorescence and biochemical studies demonstrate two types of collagen. Klin Wochenschr (1975) 1.52
Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction. J Rheumatol (1998) 1.47
Homozygosity for DNASE2 single nucleotide polymorphisms in the 5'-regulatory region is associated with rheumatoid arthritis. Ann Rheum Dis (2008) 1.45
Overview of pathogenesis of systemic sclerosis. Rheumatology (Oxford) (2009) 1.44
The collagens of the joint. Arthritis Rheum (1980) 1.44
Assessment of resident knowledge: subjective assessment versus performance on the ACR in-training examination. Acad Radiol (1999) 1.42
Failure of hormone therapy in prostate cancer involves systematic restoration of androgen responsive genes and activation of rapamycin sensitive signaling. Oncogene (2001) 1.40
Evidence of 5-lipoxygenase overexpression in the skin of patients with systemic sclerosis: a newly identified pathway to skin inflammation in systemic sclerosis. Arthritis Rheum (2001) 1.39
Analysis of the p53 tumor suppressor gene in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum (1999) 1.39
Immunohistochemical evidence for the presence of collagen type III in human arterial walls, arterial thrombi, and in leukocytes, incubated with collagen in vitro. Klin Wochenschr (1975) 1.38
Improving protein identification from peptide mass fingerprinting through a parameterized multi-level scoring algorithm and an optimized peak detection. Electrophoresis (1999) 1.37
Expression of osteopontin messenger RNA and protein in rheumatoid arthritis: effects of osteopontin on the release of collagenase 1 from articular chondrocytes and synovial fibroblasts. Arthritis Rheum (2000) 1.36
Differential transcriptome analysis of intraarticular lesional vs intact cartilage reveals new candidate genes in osteoarthritis pathophysiology. Osteoarthritis Cartilage (2008) 1.35
Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization. Am J Pathol (1998) 1.34
The gastroenterology service: a survey of general practitioners' requirements. J R Soc Med (1993) 1.33
Human IL-1Ra gene transfer into human synovial fibroblasts is chondroprotective. J Immunol (1997) 1.32
The release of microparticles by apoptotic cells and their effects on macrophages. Apoptosis (2005) 1.32
Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis. Hum Gene Ther (1996) 1.31
Immunohistochemical demonstration of a 44-KD phosphoprotein in developing rat bones. J Histochem Cytochem (1987) 1.30
Ascorbic acid (vitamin C) improves the antineoplastic activity of doxorubicin, cisplatin, and paclitaxel in human breast carcinoma cells in vitro. Cancer Lett (1996) 1.28
44-kDal bone phosphoprotein (osteopontin) antigenicity at ectopic sites in newborn rats: kidney and nervous tissues. Cell Tissue Res (1988) 1.28
Immunohistological study on collagen in cartilage-bone metamorphosis and degenerative osteoarthrosis. Klin Wochenschr (1976) 1.28
Differential expression pattern of membrane-type matrix metalloproteinases in rheumatoid arthritis. Arthritis Rheum (2000) 1.26
Invasiveness of synovial fibroblasts is regulated by p53 in the SCID mouse in vivo model of cartilage invasion. Arthritis Rheum (2001) 1.26
A new model for rheumatoid arthritis generated by engraftment of rheumatoid synovial tissue and normal human cartilage into SCID mice. Arthritis Rheum (1994) 1.26
Cathepsin B in synovial cells at the site of joint destruction in rheumatoid arthritis. Arthritis Rheum (1991) 1.26
Tissue-specificity of liver gene expression: a common liver-specific promoter element. Nucleic Acids Res (1988) 1.24
GLP-1 stimulates secretion of macromolecules from airways and relaxes pulmonary artery. Am J Physiol (1993) 1.23
Ultrastructural demonstration of apoptosis, Fas and Bcl-2 expression of rheumatoid synovial fibroblasts. J Rheumatol (1996) 1.22
Interleukin-16, produced by synovial fibroblasts, mediates chemoattraction for CD4+ T lymphocytes in rheumatoid arthritis. Eur J Immunol (1998) 1.22
The extended family and support for people with AIDS in a rural population in south west Uganda: a safety net with holes? AIDS Care (1993) 1.22
Sensorimotor cortical activity in patients with complete spinal cord injury: a functional magnetic resonance imaging study. J Neurotrauma (2002) 1.21
Liver cell specific gene transcription in vitro: the promoter elements HP1 and TATA box are necessary and sufficient to generate a liver-specific promoter. Nucleic Acids Res (1989) 1.21
Collagen formation by the hepatocyte in primary monolayer culture and in vivo. Science (1983) 1.21
Increased serum adiponectin levels in female patients with erosive compared with non-erosive osteoarthritis. Ann Rheum Dis (2009) 1.21
Expression of vascular cell adhesion molecule-1 mRNA and protein in rheumatoid synovium demonstrated by in situ hybridization and immunohistochemistry. Lab Invest (1995) 1.20
Production and specificity of antibodies against the aminoterminal region in type III collagen. Immunology (1976) 1.19
Quantitative analysis of parenchymal and vascular alterations in NO2-induced lung injury in rats. Eur Respir J (1995) 1.19
Dermal architecture and collagen type distribution. Arch Dermatol Res (1977) 1.19
Oncogenes in rheumatoid arthritis. Rheum Dis Clin North Am (1995) 1.19
The development of a community-based HIV/AIDS counselling service in a rural area in Uganda. AIDS Care (1991) 1.19
Spontaneous expression of immediately-early response genes c-fos and egr-1 in collagenase-producing rheumatoid synovial fibroblasts. Rheumatol Int (1992) 1.17
Fundamentals of pulmonary drug delivery. Respir Med (2003) 1.16
Binding of heparan sulfate to type V collagen. A mechanism of cell-substrate adhesion. J Biol Chem (1989) 1.15
Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa). Cancer Res (1999) 1.15
Collagen types in early phases of wound healing in children. Acta Chir Scand (1978) 1.14
Ultrastructural localization of type V collagen in rat kidney. J Cell Biol (1982) 1.14
Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of TIMP-1 and TIMP-3. Gene Ther (2003) 1.14
Immunochemical and biochemical study of collagen synthesis by chondrocytes in culture. Exp Cell Res (1977) 1.13
EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells. Ann Rheum Dis (2008) 1.13
HLA markers and prediction of clinical course and outcome in rheumatoid arthritis. Arthritis Rheum (1997) 1.12
Collagen in the cellular and fibrotic stages of scleroderma. Arthritis Rheum (1978) 1.12
Increased serum levels of non-collagenous matrix proteins (cartilage oligomeric matrix protein and melanoma inhibitory activity) in marathon runners. Osteoarthritis Cartilage (2000) 1.12